New order for prostate cancer treatment: chemo first, then hormones?
NCT ID NCT03069937
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether giving chemotherapy (docetaxel) before starting hormone therapy (degarelix) helps men with prostate cancer that has spread. 52 men took part. The main goal was to see how many had very low PSA levels after 10 months. The approach aims to improve disease control, but ongoing treatment is still needed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.